Abdominoplasty, Suction Lipectomy, and Ventral Hernia Repair
Customize your policy alerts
Sign up for Aetna Policy 0211 alerts
Get alerted when Policy 0211 changes without checking for updates manually.
Monitor payer policy activity
Clinical coverage rules for panniculectomy/apronectomy, abdominoplasty, suction lipectomy (including for lipedema and lymphedema), ventral/incisional hernia repair, diastasis recti, and surgical correction of adult acquired buried penis for Aetna members.
No material clinical or coverage changes in this revision.
Coverage Criteria
inv-01: Panniculectomy Medical Necessity
Panniculectomy/apronectomy is considered medically necessary when ALL of the following are met:
High-quality color frontal and side-view photographs required
inv-02: Hernia Repair — Ventral or incisional hernia repair considered medically necessary when repaired for a true hernia
Ventral or incisional hernia repair is considered medically necessary when repaired for a true hernia.
See Background: distinguish ventral hernia repair from cosmetic abdominoplasty; include size, reducibility, symptoms, fascial defect
inv-03: Suction Lipectomy for Lipedema
Suction lipectomy for lipedema is considered medically necessary when ALL of the following are met:
High-quality color photographs should accompany requests
Conservative therapy examples: compression or manual therapy per policy
inv-04: Diastasis Recti — top-level criteria node (repair considered not medically necessary)
Policy stance: not medically necessary
inv-05: Adult Acquired Buried Penis
Adult acquired buried penis surgical correction is considered medically necessary when ALL of the following are met:
High-quality photographic documentation required; correction of congenital buried penis is medically necessary when performed to prevent penile complications
inv-06: Background-based clinical criteria (informational)
Contextual criteria and guideline-based recommendations presented in the background (informational):
Based on guideline recommendations (DGP, Dutch guidelines) and systematic reviews; surgical procedures indicated when symptoms persist despite conservative therapy
Based on Laloze et al. meta-analysis: higher fat survival but increased complications
inv-07: Lipedema — Diagnostic Algorithm
Lipedema diagnosis is established when ALL history criteria AND at least one physical exam criterion are present; in equivocal cases one of the extra criteria may establish the diagnosis.
Diagnostic algorithm (overview)
- History (all A–E): A) Disproportionate fat distribution; B) Lack of influence of weight loss on disproportionate fat distribution; C) Sensitivity to pain and easy bruising in fat distribution; D) Sensitivity to touch and fatigue in extremities; E) No reduction of pain when raising extremities.
- Physical examination (one or more regions): Upper leg: disproportionate fat distribution AND circularly thickened subcutaneous fat layer; OR Lower leg: proximal and distal thickening of subcutaneous fat with slender instep (cuff-sign); OR Upper arm: significantly thickened subcutaneous fat with sudden stop at elbow; OR Lower arm: thickened subcutaneous fat with slender back of hand (cuff-sign).
- Extra criteria (equivocal cases): Either pain on bi-manual palpation OR distal fat tissue tendrils at the knee (popliteus).
From Appendix: Diagnostic Criteria for Lipedema
From Appendix: Diagnostic Criteria for Lipedema
From Appendix: Diagnostic Criteria for Lipedema
inv-08: Lipedema diagnostic criteria
Diagnosis of lipedema is established when the member meets the required medical history and physical examination criteria, with extra criteria resolving equivocal cases.
From Appendix: Diagnostic Criteria for Lipedema
From Appendix: Diagnostic Criteria for Lipedema
Used to establish diagnosis in equivocal cases
Abdominoplasty, lipoabdominoplasty, and suction lipectomy are considered cosmetic by Aetna when performed for indications other than lipedema or lymphedema. Panniculectomy/apronectomy is likewise considered cosmetic when the specific medical necessity criteria are not met. Requests for these procedures should be supported by documentation that distinguishes reconstructive/medically necessary indications (for example, panniculus producing chronic intertrigo refractory to treatment or a true hernia requiring repair) from purely aesthetic concerns.
For suction lipectomy to be considered medically necessary for lipedema, documentation must show a clinical diagnosis of lipedema and that symptoms have persisted despite an adequate trial of conservative therapy (for example compression or manual therapy) for at least 3 months. High-quality frontal and side-view photographs and objective measurements are expected to accompany requests to demonstrate the regional distribution of adipose change and symptomatology.
Panniculectomy/apronectomy is considered experimental and investigational when proposed solely to minimize the risk of hernia formation or recurrence. The policy notes that current evidence does not establish that an overhanging pannus is a primary cause of hernia formation; hernias arise from an abdominal wall defect or weakness rather than a pulling effect from redundant pannus tissue.
Several procedures are designated experimental/investigational because available evidence is insufficient to establish safety and effectiveness. These include abdominal lipectomy or correction of buried penis when performed for treatment of metabolic syndrome or as an adjunct to long-term weight loss after bariatric surgery, and adipose-derived stem cell-assisted lipotransfer (cell-assisted lipotransfer, CAL).
Published reviews and systematic analyses have raised concerns about CAL: while some studies report improved fat survival in small-volume grafts, overall the evidence is limited, heterogeneous, and includes safety uncertainties (including incomplete oncologic safety data). Consequently, CAL remains investigational pending higher-quality evidence.
A systematic review and meta-analysis of abdominal lipectomy (Seretis et al., 2015) found conflicting results across studies and, in pooled analysis of four studies (140 subjects), demonstrated no significant changes in metabolic syndrome components or insulin sensitivity after abdominal lipectomy. The authors concluded that abdominal lipectomy did not significantly affect metabolic syndrome parameters and that higher-quality studies are needed to clarify any potential metabolic benefits.
Multiple randomized trials and meta-analyses have reported less favorable outcomes with biologic mesh compared with synthetic mesh for ventral hernia repair. One randomized trial observed higher hernia recurrence with biologic versus synthetic mesh and subgroup findings suggested increased recurrence in contaminated wounds. Another multi-center randomized trial showed synthetic mesh significantly reduced hernia recurrence and markedly lowered device and hospital costs. A 4-RCT meta-analysis found that biologic mesh was associated with increased hernia recurrence and, in some analyses, higher surgical site infection rates compared with synthetic mesh.
This Clinical Policy Bulletin (CPB) provides a partial, general description of plan benefits intended to assist in administering coverage decisions. It is not a contract and does not replace plan-specific documents. Coverage determinations remain subject to the terms, limitations, and exclusions of individual benefit plans, and prior authorization or other plan requirements may apply.
Repair of diastasis recti is considered not medically necessary. The policy states that diastasis recti—a thinning or separation of the anterior abdominal wall fascia—does not represent a true hernia and is of no clinical significance based on the cited clinical literature.
Cell-assisted lipotransfer (CAL) remains investigational/experimental. Systematic reviews and meta-analyses report that while CAL can increase fat survival for small-volume grafts, the evidence base is limited, heterogeneous, and shows higher complication rates in some series. Unresolved issues include optimal methods, long-term safety and oncologic risk; therefore CAL is not established as superior to conventional lipotransfer.
The available randomized trials and pooled analyses do not demonstrate superiority of biologic mesh over synthetic mesh for ventral hernia repair. Instead, evidence indicates biologic mesh can be associated with higher hernia recurrence and, in some studies, higher rates of surgical site infection—along with substantially higher prosthetic costs—supporting a synthetic-first approach in many elective and contaminated cases.
Coding
| 0437T | Implantation of non-biologic or synthetic implant for fascial reinforcement of the abdominal wall |
| 15830 | Excision, excessive skin and subcutaneous tissue (including lipectomy); abdomen, infraumbilical panniculectomy [documentation required] |
| 49591 | Repair of anterior abdominal hernia(s)... total length of defect(s); less than 3 cm, reducible |
| 49592 | less than 3 cm, incarcerated or strangulated |
| 49593 | 3 cm to 10 cm, reducible |
| 49594 | 3 cm to 10 cm, incarcerated or strangulated |
| 49595 | greater than 10 cm, reducible |
| 49596 | greater than 10 cm, incarcerated or strangulated |
| 49613 | Repair... recurrent... less than 3 cm, reducible |
| 49614 | less than 3 cm, incarcerated or strangulated |
| E65 | Localized adiposity [abdomen] |
| K43.0-K43.9 | Ventral hernia |
| L30.4 | Erythema intertrigo [chronic, documentation required] |
| L98.7 | Excessive and redundant skin and subcutaneous tissue |
| M79.3 | Panniculitis [abdomen] |
| R60.9 | Edema, unspecified [lipedema] |
| L90.0 | Lichen sclerosus et atrophicus |
| Q55.64 | Hidden penis |
| Z98.84 | Bariatric surgery status |
| E88.81 | Metabolic syndrome |
| No codes listed |
Provider Actions / Prior Authorization & Documentation
Prior authorization required for listed CPT codes when selection criteria apply
Prior authorization is implied for the listed CPT codes when those codes are subject to the policy’s selection criteria; documentation supporting medical necessity must accompany the request (e.g., photographic and clinical records).
Document prior conservative therapy for lipedema surgery
For lipedema patients, prior authorization requests for suction lipectomy/liposuction must document that symptoms persisted despite thorough conservative therapy; the policy expects documentation that conservative measures were attempted.
- State duration and type of conservative therapy attempted and clinical response.
- Reference guideline-based recommendation that surgery is indicated only after inadequate response to conservative measures.
Justify use of biologic mesh on prior authorization
If a biologic mesh is proposed for ventral hernia repair, the prior authorization should include a clear clinical justification comparing biologic versus synthetic mesh and rationale for selecting biologic mesh.
- Provide clinical reasons the patient is not a candidate for synthetic mesh despite evidence favoring synthetic mesh for lower recurrence and cost.
- Include wound contamination status and prior mesh history when relevant.
Follow plan provisions for prior authorization
Check the member’s specific plan provisions for prior authorization requirements — Clinical Policy Bulletins summarize criteria but do not replace plan-level prior authorization rules.
- Follow the plan’s prior authorization procedures and benefit documents for final coverage determination.
- CPBs are a partial description and do not constitute a contract.
Document ≥3 months of conservative therapy before suction lipectomy for lipedema
Suction lipectomy for lipedema requires documentation that the member received conservative therapy for at least 3 months (e.g., compression or manual therapy) before surgery is considered.
- State start and end dates for conservative measures and describe the member’s response over the ≥3 month period.
- Examples of conservative therapy include compression and manual therapy (complex physical therapy).
Attempt recommended conservative measures before surgery
Prior to considering surgery, document that first‑line conservative measures were attempted: manual lymphatic drainage, compression therapy, exercise, skin care, and weight control. Surgery is considered when these are inadequate.
- List specific conservative modalities used (e.g., manual lymphatic drainage) and objective measures (waist/limb circumferences, BMI).
- Indicate clinician assessments showing inadequate response to conservative care.
Consider synthetic mesh as first‑line; document reasons if choosing biologic mesh
When planning ventral hernia repair, synthetic mesh should be considered as the first‑line implant, including in some contaminated cases; if biologic mesh is chosen, document why synthetic mesh is unsuitable.
- Provide clinical rationale if bypassing a synthetic‑first approach (e.g., intolerance, prior synthetic mesh complications).
- Include wound classification (clean/contaminated) and supporting literature if available.
When uncertain, follow plan documents for authorization
If plan‑level guidance is unclear, refer to the member’s plan documents for any additional authorization or documentation requirements to avoid denials.
- Plan documents determine final prior authorization rules and benefit limitations.
- When in doubt, obtain prior authorization per the member’s plan.
Submit high‑quality photographic and clinical documentation
Include high‑quality color frontal and side‑view photographs (pannus lifted when relevant) and clinical records describing symptoms, duration, and prior treatments with the authorization or claims submission.
- Photos should clearly show panniculus or affected regions and be dated.
- Attach office notes documenting symptom severity, duration, and prior conservative therapy.
Document diagnosis and prior conservative therapy before surgery for lipedema
For pre‑surgical lipedema evaluations, document the diagnosis, the prior conservative therapy attempts (e.g., complex decongestive therapy), and objective measurements such as waist and limb circumferences, BMI, and functional/psychosocial scoring.
- Specify types and dates of conservative therapy (compression, manual therapy, exercise, skin care).
- Include objective measures and clinician assessment of surgical candidacy.
Document lipedema history and physical exam criteria per appendix
When lipedema is suspected, document the required history findings (A–E) and at least one physical‑exam regional criterion from the appendix to establish the diagnosis per the policy’s diagnostic algorithm.
- History items include disproportionate fat distribution; lack of influence of weight loss; sensitivity to pain and easy bruising; sensitivity to touch and fatigue; and no reduction of pain with elevation.
- Physical exam must show one or more region‑specific findings (upper/lower leg or arm features) or, in equivocal cases, an extra criterion.
Include appendix‑based diagnostic evidence for lipedema
Include diagnostic documentation that maps to the appendix (medical history items A–E and physical exam criteria or extra criteria) when requesting coverage for lipedema procedures.
- Cite which appendix items were observed and attach corresponding exam findings and photographs.
- Use the appendix algorithm (history + physical ± extra criteria) to demonstrate that diagnostic thresholds are met.
Coding/coverage denial risk when indication is cosmetic
Do not submit CPT codes for procedures when the indication is purely cosmetic or when the request does not meet the Clinical Policy Bulletin’s medical necessity criteria; such submissions risk denial (e.g., suction‑assisted lipectomy trunk codes when not for lipedema/lymphedema).
- Verify the indication clearly on the claim or prior auth; cosmetic indications are excluded from coverage.
- Examples: CPT 15877 (suction assisted lipectomy; trunk) is covered only if selection criteria are met.
Limited‑quality evidence for liposuction may lead to denials
Be aware that evidence supporting liposuction for lipedema is limited in quality (primarily uncontrolled before‑and‑after studies); payers may deny coverage if clinical effectiveness is judged insufficiently supported by evidence.
- If relying on evidence, include clinician justification and patient‑level objective measures to support medical necessity.
- Guideline endorsements and documented failure of conservative therapy strengthen the request.
Document rationale when selecting biologic mesh — impacts recurrence and infection
Mesh selection affects outcomes: biologic mesh has been associated with higher hernia recurrence and, in some analyses, higher surgical‑site infection and cost compared with synthetic mesh — document clinical reasons if biologic mesh is used.
- Include trial data or patient‑specific factors that justify biologic mesh over synthetic alternatives.
- Document wound contamination status and prior repair history to support mesh choice.
CPB is a partial benefit summary—follow plan provisions
Clinical Policy Bulletins provide a partial description of plan benefits and do not constitute a contract; failure to follow the member’s plan provisions (including prior authorization rules) may affect coverage decisions.
- Confirm benefits and any exclusions in the member’s plan documents before proceeding.
- Obtain prior authorization per plan rules to reduce risk of post‑service denial.
Background
Abdominoplasty (commonly called a tummy tuck) is a surgical procedure that removes excess skin and subcutaneous fat and may include tightening of the abdominal wall musculature. Aetna classifies abdominoplasty as a cosmetic procedure when it does not meet reconstructive or medical necessity criteria because it is not associated with demonstrable functional improvement in the absence of specific medical indications.
To distinguish reconstructive ventral or incisional hernia repair from cosmetic abdominoplasty, documentation should include size, reducibility, symptoms, and confirmation of a fascial defect; high-quality photographs and clinical records are necessary to support the distinction.
Definitions
Revision History
Policy originally became effective.
Policy last reviewed.
Next scheduled policy review date.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.